LongeVC | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights

---

LongeVC is a venture capital firm based in Lugano, Switzerland, founded in 2016. The company specializes in supporting early-stage biotech and longevity-focused founders, helping them gain industrial momentum, raise capital, and shape the future of the biotech industry. LongeVC aims to build a broad community of biotech innovators by funding companies in complementary sectors and facilitating collaboration among them.

🛍️ LongeVC Product and Pricing News →

👔 LongeVC CEO, Management and Leadership Team →

⚔️ LongeVC Alternatives and Competitors →

💼 LongeVC Hiring and Layoffs →

🤖 LongeVC Developer, Integration and Automation News →

📈 LongeVC Financials, Fundraising and Valuation News →

---

🛍️ LongeVC Product and Pricing News

• LongeVC's portfolio company HautAI launched SkinGPT, an AI platform for personalized virtual skincare try-ons, using generative AI to simulate product effects and skin changes.
• Sergey Jakimov, managing partner at LongeVC, emphasized at the Bioinnovate Symposium that brilliant science alone is insufficient to build a successful biotech business.
• LongeVC's Managing Partner and Head of Investor Relations, Aurora Griffin, will speak at The Livelong Experience event in Palm Beach, Florida, on March 28-29.
• On February 20th, 2025, Sergey Jakimov, Managing Partner at LongeVC, will deliver a keynote speech at the BioInnovate 2025 Symposium in Stevenage.
• Sergey Jakimov, co-founder and partner at LongeVC, emphasizes a pragmatic, disease-driven approach to longevity by investing in treatments for age-related conditions like cancer and neurodegenerative diseases.

• Rubedo Life Sciences, a portfolio company of LongeVC, announced plans for a Phase 1 clinical trial of their GPX4 modulator RLS-1496 targeting aging cells.
• LongeVC will participate as a sponsor in the Longevity Science Summit in Miami, aiming to raise $250K for longevity research projects.
• Garri Zmudze of LongeVC participated in an investors panel at ARDD2024 discussing the development of the longevity biotechnology industry.

---

👔 LongeVC CEO, Management and Leadership Team

• Konstantinos Maitos

  
  Chief Financial Officer
  [email protected]

---

⚔️ LongeVC Alternatives and Competitors

• Aeravti Ventures
|
• Black Diamond Ventures

---

💼 LongeVC Hiring and Layoffs

• Aurora Griffin has joined LongeVC as Managing Partner and Head of Investor Relations to scale the $250M LongeVC II fund and develop AniVC's $35M fund I.
• Hyeyoung Eléonore S. has joined LongeVC as a Venture Scout in Norway.

---

🤖 LongeVC Developer, Integration and Automation News

• LongeVC's portfolio company Longenesis has partnered with Novartis Baltics on a pilot project to transform cardiovascular disease treatment and prevention in Latvia.
• Unnatural Products Inc., a LongeVC portfolio company, is pioneering AI-powered macrocyclic molecule design in collaboration with Merck to enhance drug discovery for complex diseases.

---

📈 LongeVC Financials, Fundraising and Valuation News

• LongeVC has backed SiPhox Health, a portfolio company, in its latest funding round as SiPhox doubled its revenue in 2024 and advanced in product development and R&D.
• LongeVC's portfolio company Melio, led by Mridu Sinha, received a $3.5M grant to develop a platform for rapid identification of bloodstream infections, starting with neonatal sepsis.
• LongeVC participated in Proton Intelligence Inc.'s $6.95 million seed financing round for their Continuous Potassium Monitoring platform.
• LongeVC has invested in Proton Intelligence, a company developing the first minimally invasive continuous potassium monitoring devices to improve management of chronic conditions.
• LongeVC's comparative indices for 2023 show slight improvements in net turnover, equity capital, fixed assets, balance, tangible assets, and liquidity.

• Artem Trotsyuk, operating partner at LongeVC, noted a trend of larger companies acquiring smaller biotechs to access new medicines and technologies.

---

People also viewed

• Skaala
|
• Lemonade Stand
|
• Health Founders
|
• Tesonet
|
• Thorgate
|
• Siena Secondary Fund
|
• Trind Ventures
|
• ZGI Capital
|
• BADideas.fund
|
• Superangel
|
• Bridgio
|
• Launchpad Capital